Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06120803 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Esomeprazole and Radiation Induced Esophagitis

Study acronym: EERENs
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Jul 30, 2027 to Dec 30, 2027
    • Study completion date: Jan 31, 2028 to Jun 30, 2028
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Study description expanded, about 434 words
    v3
  4. Eligibility criteria shortened, about 18 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Thoracic radiation therapy combined with chemotherapy (with or without immunotherapy) is the cornerstone of management in patients with locally advanced non-small cell lung cancer (NSCLC).
Trial Details
NCT Number NCT06120803
Lead Sponsor Rush University Medical Center
Conditions
(from sponsor)		 Radiation Esophagitis, Locally Advanced Lung Carcinoma
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov